{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T04:29:24Z","timestamp":1765772964639,"version":"3.44.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Womens Ment Health"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed for mood disorders in pregnancy, though studies regarding effects on fetal behavior are conflicting. Previous studies have suggested that fetuses exposed to these medications in the third trimester may have decreased fetal heart rate variability. Since changes in variability may affect the interpretation of antenatal testing, clinicians should be aware of those medications that may impair effective testing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A retrospective observational cohort study was performed to compare nonstress test (NST) parameters of fetuses exposed to SSRIs with unexposed fetuses at 36\u00a0weeks gestation. Subjects were excluded if they had multiple gestations, fetal anomalies including growth restriction, illicit substance use or use of other psychotropic medications. NSTs were compared for fetal baseline heart rate, variability, time to reactivity, number of accelerations over time, and number of fetal movements over time.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of 219 participants, 12 were taking an SSRI\/SNRI at the time of their 36-week NST. There were no significant differences in demographics or indications for NST between groups. NSTs were reactive in 92% of those taking an SSRI\/SNRI and in 97% of those not taking an SSRI\/SNRI. Time to reactivity [8.6\u00a0min vs. 12.5\u00a0min], baseline heart rate [142\u00a0bpm vs. 139\u00a0bpm], and heart rate variability [12.1\u00a0bpm vs. 11.7\u00a0bpm] were all similar between the two groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Though limited by sample size, lack of pharmacologic data and potential confounding by indication, the study suggests SSRI use is not associated with any significant changes in NST. Clinicians should be reassured that NST assessment remains a useful means of determining fetal wellbeing in patients using these medications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00737-025-01607-9","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T01:51:42Z","timestamp":1751507502000},"page":"1309-1317","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Maternal antidepressant effects on the fetal nonstress test"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6366-9292","authenticated-orcid":false,"given":"Emily","family":"McCauley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4464-6423","authenticated-orcid":false,"given":"Samantha","family":"Gawrys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5982-7764","authenticated-orcid":false,"given":"Jason","family":"Benedict","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7660-639X","authenticated-orcid":false,"given":"Jonathan","family":"Schaffir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"issue":"141","key":"1607_CR1","first-page":"1232","volume":"2023","author":"American College of Obstetricians and Gynecologists","year":"2023","unstructured":"American College of Obstetricians and Gynecologists (2023) Screening and diagnosis of mental health conditions during pregnancy and postpartum. Clinical Practice Guideline No. 4. Obstet Gynecol 2023(141):1232\u201361","journal-title":"Obstet Gynecol"},{"issue":"5","key":"1607_CR2","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1097\/AOG.0b013e31816c441a","volume":"111","author":"FC Bruce","year":"2008","unstructured":"Bruce FC, Berg CJ, Hornbrook MC et al (2008) Maternal morbidity rates in a managed care population. Obstet Gynecol 111(5):1089\u20131095. https:\/\/doi.org\/10.1097\/AOG.0b013e31816c441a","journal-title":"Obstet Gynecol"},{"key":"1607_CR3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.neuroscience.2016.02.037","volume":"342","author":"S Brummelte","year":"2017","unstructured":"Brummelte S, Mc Glanaghy E, Bonnin A, Oberlander TF (2017) Developmental changes in serotonin signaling: Implications for early brain function, behavior and adaptation. Neuroscience 342:212\u2013231. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.02.037","journal-title":"Neuroscience"},{"key":"1607_CR4","doi-asserted-by":"publisher","first-page":"680177","DOI":"10.3389\/fpsyt.2021.680177","volume":"12","author":"KSJ Campbell","year":"2021","unstructured":"Campbell KSJ, Collier AC, Irvine MA et al (2021) Maternal serotonin reuptake inhibitor antidepressants have acute effects on fetal heart rate variability in late gestation. Front Psychiatry 12:680177. https:\/\/doi.org\/10.3389\/fpsyt.2021.680177","journal-title":"Front Psychiatry"},{"key":"1607_CR5","doi-asserted-by":"publisher","first-page":"106129","DOI":"10.1016\/j.earlhumdev.2024.106129","volume":"198","author":"KSJ Campbell","year":"2024","unstructured":"Campbell KSJ, Brain U, Hanley GE, Oberlander TF, Lim KI (2024) Maternal depressed mood and serotonergic antidepressant treatment during pregnancy differentially shape the continuity between fetal-newborn neurobehaviour. Early Hum Devel 198:106129. https:\/\/doi.org\/10.1016\/j.earlhumdev.2024.106129","journal-title":"Early Hum Devel"},{"issue":"5","key":"1607_CR6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/imhj.20192","volume":"29","author":"JNI Dieter","year":"2008","unstructured":"Dieter JNI, Emory EK, Johnson KC, Raynor BD (2008) Maternal depression and anxiety effects on the human fetus: Preliminary findings and clinical implications. Infant Ment Health J 29(5):420\u2013441. https:\/\/doi.org\/10.1002\/imhj.20192","journal-title":"Infant Ment Health J"},{"key":"1607_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1196\/annals.1376.036","volume":"1094","author":"EK Emory","year":"2006","unstructured":"Emory EK, Dieter JNI (2006) Maternal depression and psychotropic medication effects on the human fetus. Ann N Y Acad Sci 1094:287\u2013291. https:\/\/doi.org\/10.1196\/annals.1376.036","journal-title":"Ann N Y Acad Sci"},{"key":"1607_CR8","unstructured":"Greenberg MB, Druzin ML (2021) Antepartum fetal evaluation. In Landon MB, Galan HL, Jauniaux ERM et al, (eds). Gabbe\u2019s Obstetrics: Normal and Problem Pregnancies, 8th ed. Elsevier: Amsterdam,\u00a0 514\u2013538 e1"},{"key":"1607_CR9","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1017\/S0954579418000639","volume":"30","author":"HC Gustafsson","year":"2018","unstructured":"Gustafsson HC, Goodman SH, Feng T et al (2018) Major depressive disorder during pregnancy: psychiatric medications have minimal effects on the fetus and infant yet development is compromised. Dev Psychopathol 30:773\u2013785. https:\/\/doi.org\/10.1017\/S0954579418000639","journal-title":"Dev Psychopathol"},{"key":"1607_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/GRF.0b013e3182802cad","volume":"56","author":"E Kopel","year":"2013","unstructured":"Kopel E, Hill WC (2013) The effect of abused substances on antenatal and intrapartum fetal testing and well being. Clin Obstet Gynecol 56:154\u2013165. https:\/\/doi.org\/10.1097\/GRF.0b013e3182802cad","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"1607_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00737-023-01389-y","volume":"27","author":"A Lendel","year":"2024","unstructured":"Lendel A, Richards R, Benedict J, Lynch C, Schaffir J (2024) Incidence of postpartum depression in low-income cannabis users with and without a history of depression. Arch Womens Ment Health 27(1):145\u2013151. https:\/\/doi.org\/10.1007\/s00737-023-01389-y","journal-title":"Arch Womens Ment Health"},{"issue":"3","key":"1607_CR12","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/AOG.0b013e3181841395","volume":"112","author":"GA Macones","year":"2008","unstructured":"Macones GA, Hankins GDV, Spong CY, Hauth J, Moore T (2008) The 2008 National Institute of Child Health and Human Development workshop report on electronic fetal monitoring. Obstet Gynecol 112(3):661\u2013666","journal-title":"Obstet Gynecol"},{"issue":"8","key":"1607_CR13","doi-asserted-by":"publisher","first-page":"101053","DOI":"10.1016\/j.ajogmf.2023.101053","volume":"5","author":"E McCauley","year":"2023","unstructured":"McCauley E, Rood K, Benedict J, Koenig N, Schaffir J (2023) Maternal mood and anxiety effects on the fetal nonstress test. Am J Obstet Gynecol MFM 5(8):101053. https:\/\/doi.org\/10.1016\/j.ajogmf.2023.101053","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"10","key":"1607_CR14","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1038\/npp.2011.67","volume":"36","author":"EJH Mulder","year":"2011","unstructured":"Mulder EJH, Ft Ververs F, de Heus R, Visser GHA (2011) Selective serotonin reuptake inhibitors affect neurobehavioral development in the human fetus. Neuropsychopharmacology 36(10):1961\u20131971. https:\/\/doi.org\/10.1038\/npp.2011.67","journal-title":"Neuropsychopharmacology"},{"key":"1607_CR15","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1080\/02646838.2023.2257730","volume":"43","author":"TM Pinto","year":"2023","unstructured":"Pinto TM, Nogueira-Silva C (2023) Figueiredo B. J Reprod Infant Psychol 19:1\u201314. https:\/\/doi.org\/10.1080\/02646838.2023.2257730","journal-title":"J Reprod Infant Psychol"},{"issue":"2","key":"1607_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.clp.2019.02.004","volume":"46","author":"ER Raffi","year":"2019","unstructured":"Raffi ER, Nunacs R, Cohen LS (2019) Safety of psychotropic medications during pregnancy. Clin Perinatol 46(2):215\u2013234. https:\/\/doi.org\/10.1016\/j.clp.2019.02.004","journal-title":"Clin Perinatol"},{"issue":"1","key":"1607_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1203\/PDR.0b013e31821ba11a","volume":"70","author":"D Rurak","year":"2011","unstructured":"Rurak D, Lim K, Sanders A, Brain U, Riggs W, Oberlander TF (2011) Third trimester fetal heart rate and Doppler middle cerebral artery blood flow velocity characteristics during prenatal selective serotonin reuptake inhibitor exposure. Pediatr Res 70(1):96\u2013101. https:\/\/doi.org\/10.1203\/PDR.0b013e31821ba11a","journal-title":"Pediatr Res"},{"issue":"3","key":"1607_CR18","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.clp.2009.06.002","volume":"36","author":"AL Salisbury","year":"2009","unstructured":"Salisbury AL, Ponder KL, Padbury JF, Lester BM (2009) Fetal effects of psychoactive drugs. Clin Perinatol 36(3):595\u2013619. https:\/\/doi.org\/10.1016\/j.clp.2009.06.002","journal-title":"Clin Perinatol"},{"key":"1607_CR19","doi-asserted-by":"publisher","first-page":"100181","DOI":"10.1016\/j.cpnec.2023.100181","volume":"14","author":"L Semeia","year":"2023","unstructured":"Semeia L, Bauer I, Sippel K, Hartkopf J, Schaal NK, Preissl H (2023) Impact of maternal emotional state during pregnancy on fetal heart rate variability. Compr Psychoneuroendocrinol 14:100181. https:\/\/doi.org\/10.1016\/j.cpnec.2023.100181","journal-title":"Compr Psychoneuroendocrinol"},{"issue":"6","key":"1607_CR20","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.ajog.2016.07.011","volume":"215","author":"LC Susser","year":"2016","unstructured":"Susser LC, Sansone SA, Hermann AD (2016) Selective serotonin reuptake inhibitors for depression in pregnancy. Am J Obstet Gynecol 215(6):722\u2013730. https:\/\/doi.org\/10.1016\/j.ajog.2016.07.011","journal-title":"Am J Obstet Gynecol"},{"key":"1607_CR21","unstructured":"Umana OD, Siccardi MA (2020) Prenatal Non-stress Test. [Updated 2020 Aug 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537123\/"}],"container-title":["Archives of Women's Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-025-01607-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00737-025-01607-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-025-01607-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:27:35Z","timestamp":1757921255000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00737-025-01607-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1607"],"URL":"https:\/\/doi.org\/10.1007\/s00737-025-01607-9","relation":{},"ISSN":["1434-1816","1435-1102"],"issn-type":[{"type":"print","value":"1434-1816"},{"type":"electronic","value":"1435-1102"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"This study was approved by the Ohio State University IRB.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Due to retrospective collection of existing data, informed consent was waived by the IRB.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors provide consent for publication of the manuscript should it be accepted.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}